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Background
Cannabinoids are psychoactive compounds with many
pharmacological properties such as analgesia, sedation
and catalepsy most which are mediated by CB1 receptors.
In the present study, we evaluated whether the ovarian sex
hormones are involved in the cannabinoid-induced cata-
lepsy and analgesia in ovarectomized (OVX) female mice.
Materials and methods
Female swiss mice (weighing 25-30 g) were divided into 3
main groups: unoperated, sham-operated and OVX. Both
the catalepsy and analgesia induced by different doses of
synthetic cannabinoid WIN 55,212-2 (2 and 4 mg/kg,
i.p.) were examined in three groups in the presence or
absence of the CB1 antagonist AM251. We also evaluated
effects of estradiol and progesterone on catalepsy and
analgesia induced by WIN 55,212-2 in OVX group.
Results
WIN 55,212-2 caused (P<0.001) catalepsy and analgesia
in three groups in a dose-dependent manner which was
inhibited by AM251 (P<0.001). Pretreatment with estra-
diol caused no effect on cannabinoid-induced catalepsy
or analgesia in OVX group. However, progesterone
exerted a strong enhancing effect (P<0.05) on catalepsy or
analgesia induced by low dose WIN 55,212-2 in OVX
mice.
Conclusions
The present data demonstrated for the first time that ovar-
ian female hormone progesterone is involved in both can-
nabinoid-induced catalepsy and analgesia in female mice.
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